2019 annual financial data

Theravance Biopharma, Inc. 2019 Operating margin

Theravance Biopharma, Inc. 2019 operating margin with verified reported values.

Direct answer

Operating margin was -343.14%.

Operating income was -251,915,000 USD and net income was -236,455,000 USD.
Operating cash flow was -238,197,000 USD.

Get free Theravance Biopharma, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
73,414,000 USD
Operating income
-251,915,000 USD
Net income
-236,455,000 USD
Operating cash flow
-238,197,000 USD